Volver a News
NOTICIA
IAM Patent 1000 Annual Ranking
24 de October, 2024
Recognition in the Silver category of the IAM Patent 1000 awards
The Firm has been awarded ‘Silver’ in the Patent Litigation category according to the annual ranking of the IAM Patent 1000 directory.
In addition, Jesús Muñoz-Delgado stands out in the ‘Gold’ category as a ‘Global Leader’, for his specialisation in Life Sciences, and specifically in patent matters in the biotechnology sector. Recognised for his strategic advice, he is involved in pan-European disputes and handles complex patent litigation with great skill.
To be included in IAM Global Leaders, practitioners must be ranked in the Golden category of the IAM Patent 1000, the annual benchmark directory that highlights the top law firms and specialists in the world’s most relevant patent jurisdictions.
More information about
Gómez-Acebo & Pombo
01 Oct, 2026 
PUBLICACIÓN
21 Sep, 2026
Pharma & Healthcare No. 50
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
21 Sep, 2026 
PUBLICACIÓN
28 Jul, 2026
Derogations from the principle of supervision in the home Member State in respect of information society services and control over content by means of an algorithm
The Court (Grand Chamber) defines the scope of derogations from the principle of supervision in the home Member State for information society services on grounds of public policy, security and safety, clarifying the distinction between general prohibitions and individualized measures directed at specific providers. It also provides important criteria regarding the liability of digital platforms, holding that control exercised by means of algorithms may preclude the application of the exemption from liability provided for data hosting services.
28 Jul, 2026
PUBLICACIÓN
23 Jun, 2026
Pharma & Healthcare No. 49
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
23 Jun, 2026
PUBLICACIÓN
30 Apr, 2026
Pharma & Healthcare No. 48
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
30 Apr, 2026
PUBLICACIÓN
29 Apr, 2026
Limitation of a patent and the Unified Patent Court’s ‘long arm’
We analyse the problems that arise when a claim is filed with the UPC for infringement of a unitary patent and, at the same time, for infringement of the validation of the basic European patent in States that are not party to the Agreement on a Unified Patent Court, and the claimant solely limits the unitary patent (because the defendant only files a counterclaim for revocation of the unitary patent with said court, but does not initiate any parallel revocation proceedings with the competent national court against the validations of the basic European patent in States that are not party to said agreement).
29 Apr, 2026
PUBLICACIÓN
06 Mar, 2026
The long arm of the Unified Patent Court based on the "event giving rise to the infringement" and considerations on the application of lex loci protectionis
This paper analyses the decision of the Mannheim Local Division of 2 October 2025, where the Unified Patent Court (UPC) justifies its jurisdiction on the basis of shipment of products from a UPC territory by company listed as authorized representative in the EC and UK markets as event giving rise to damage. Furthermore, although the applicable law with regard to the infringement of the European patent validated in States that are not party to the Agreement on a Unified Patent Court is the national law of those States, with regard to the scope of patent protection, the UPC imposes on the defendant—unduly—the burden of proving the specifics of national law.
06 Mar, 2026
PUBLICACIÓN
26 Feb, 2026
Pharma & Healthcare No. 47
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
26 Feb, 2026
PUBLICACIÓN
29 Jan, 2026
On Call Protocol for the Alimentaria and Hostelco 2026 Trade Fairs
In preparation for the Alimentaria and Hostelco 2026 trade fairs, the Commercial Section of the Barcelona First Instance Court has approved a rapid response protocol to deal promptly with any potential conflicts relating to intellectual and industrial property rights (patents,trademarks, designs, and copyright), as well as trade secrets and unfair competition issues that may arise during these events.
29 Jan, 2026
PUBLICACIÓN
27 Jan, 2026
Jurisdiction of national courts of States party to the Agreement on a Unified Patent Court in respect of actions relating to classic European patents during the transitional period
During the transitional period of the Agreement on a Unified Patent Court, national courts retain jurisdiction to hear cases concerning classic European patents, without the need for the proprietor to have exercised the opt-out option, i.e. without the need to have excluded the jurisdiction of the Unified Patent Court over such patents. However, the Venice Court ruling discussed here considers that national courts may only be used if the opt-out has been exercised, contradicting the provisions of Article 83 of the Agreement.
27 Jan, 2026